Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120 - Test2 - elhamkhani - TriplyDB

Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120

Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120

http://www.wikidata.org/entity/Q39612212

about

Drug-eluting fibers for HIV-1 inhibition and contraception Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing Regulation of Tsg101 expression by the steadiness box: a role of Tsg101-associated ligase The UBAP1 subunit of ESCRT-I interacts with ubiquitin via a SOUBA domain Essential role of hIST1 in cytokinesis.A lectin isolated from bananas is a potent inhibitor of HIV replication Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism Characterizing the anti-HIV activity of papuamide A Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation Preferences for the selection of unique tRNA primers revealed from analysis of HIV-1 replication in peripheral blood mononuclear cells COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells Efficient trapping of HIV-1 envelope protein by hetero-oligomerization with an N-helix chimera.Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides.HIV Genome-Wide Protein Associations: a Review of 30 Years of Research Antigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cells Structural Insights into HIV-1 Vif-APOBEC3F Interaction PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo Crystal Structure of the Neutralizing Llama VHH D7 and Its Mode of HIV-1 gp120 Interaction Structural Insights into the Anti-HIV Activity of the Oscillatoria agardhii Agglutinin Homolog Lectin Family Broad Antiviral Activity and Crystal Structure of HIV-1 Fusion Inhibitor Sifuvirtide A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition Structural Basis of Potent and Broad HIV-1 Fusion Inhibitor CP32M A next-generation cleaved, soluble HIV-1 Env trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies Sensitivity of human immunodeficiency virus type 1 to fusion inhibitors targeted to the gp41 first heptad repeat involves distinct regions of gp41 and is consistently modulated by gp120 interactions with the coreceptor Mitochondrial glutaminase release contributes to glutamate-mediated neurotoxicity during human immunodeficiency virus-1 infection V3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodies Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step Membrane-anchored HIV-1 N-heptad repeat peptides are highly potent cell fusion inhibitors via an altered mode of action Identification and characterization of the host protein DNAJC14 as a broadly active flavivirus replication modulator Impact of the HIV-1 env genetic context outside HR1-HR2 on resistance to the fusion inhibitor enfuvirtide and viral infectivity in clinical isolates Allosteric modulation of the HIV-1 gp120-gp41 association site by adjacent gp120 variable region 1 (V1) N-glycans linked to neutralization sensitivity Drug synergy of tenofovir and nanoparticle-based antiretrovirals for HIV prophylaxis HIV-1 Env C2-V4 diversification in a slow-progressor infant reveals a flat but rugged fitness landscape Identification of a cluster of HIV-1 controllers infected with low replicating viruses CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection The Low-Cost Compound Lignosulfonic Acid (LA) Exhibits Broad-Spectrum Anti-HIV and Anti-HSV Activity and Has Potential for Microbicidal Applications The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry Inhibition Grifonin-1: a small HIV-1 entry inhibitor derived from the algal lectin, Griffithsin Human Immunodeficiency Virus Type 1 Subtype B Ancestral Envelope Protein Is Functional and Elicits Neutralizing Antibodies in Rabbits Similar to Those Elicited by a Circulating Subtype B Envelope

P2860

Q21133885-572F754D-BAF7-4F22-A9C2-BD159D7B8232 Q24294385-9FB52DA9-FF58-4CF4-8BC1-57EF72685E81 Q24303431-F8EC1556-190A-429E-B89F-A6D69E256761 Q24306898-7770A0CA-A369-43BE-A7FD-677F640ACA2F Q24314468-0A426E34-1DFD-4711-86BE-AF64D00E1446 Q24629155-9A2A5330-ACC3-4ADE-BD4D-A1A41E3D5206 Q24644811-B10D80F5-3D59-439E-AB6C-B455925693C7 Q24645399-1325CA1F-157C-48B3-9ADD-57586F69B6BD Q24651042-CC15A38A-410D-4B9E-B91C-1F05467A804D Q24672209-8DDDC133-F907-4EDD-B400-E57DFAB18B14 Q24791889-C03456A4-B5CD-44A4-AA5F-C188EBA0DAC7 Q24806175-EAA4E491-09BA-4127-8801-E0DEF3651BC1 Q24811678-8540F0BD-BDB1-43C1-8B1B-C4112AE3FCBD Q24816124-126C54B1-2EEF-443A-B8FF-3AC86D8078DB Q26746070-F1CF69C5-4316-4526-B3F2-0F14E75E183D Q27320687-483C8D36-70AF-4505-9A47-B8D37F5EB118 Q27321018-D2E2E848-5205-4914-BD90-53418718F020 Q27324710-D382BF5D-D9B0-4276-9B40-32EA6485EC72 Q27661588-CDC38D56-19E9-4C64-B1B2-E548836F860F Q27671174-2AAFBA85-B9DB-4481-9D94-1D1E9DB2EDC5 Q27676641-277FBAC0-83CD-4324-A0F1-724CCC654612 Q27676864-196EE955-152E-4386-8950-AF7973EDE108 Q27679547-4BDDC11A-DF6C-4868-BC73-8187816955D9 Q28299280-0F1A055F-2653-458A-AD1C-D10FCE332451 Q28346124-59054986-C31E-4D5B-B8EA-0D9375631963 Q28396045-FA81C90F-2AE0-4877-888B-9A890093AFAE Q28469283-1845DFB3-CA92-49B4-AAF6-E2FFC6572BCA Q28474499-7E090AFC-EA90-43D6-BA50-5D255927F682 Q28475682-5B8E64E6-A48D-42FB-9040-1FDD9D2A1028 Q28476726-1A00E444-1EA9-4FF7-8CB1-5CE8DB3B9D40 Q28478943-6FA14652-5FB2-46B3-9B80-AD9697A472FD Q28485983-3BF6D143-A3B7-403C-A285-77E953A98F87 Q28486428-D4CAB133-644C-44D1-BB7D-EE89E102F064 Q28487168-A583A5B1-CF0F-4DC0-9157-7A4C81B22C53 Q28534737-E6FF7AA1-CD0D-4694-ACC4-0E593E5725E6 Q28542878-B8EDF501-2D41-4909-A43C-8BF5518FC6B8 Q28546014-4A239AD2-707A-41C1-9F4F-ACF2B71EDD4D Q28552932-B1E82BFE-8A6D-4C05-80C5-F9A94FC50EE9 Q28744163-122F9DDC-DE5B-4144-BC0E-DD8999A2DC32 Q29307502-583D2AA7-F303-4A07-86CC-7764E2CC05D1

P2860

Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120

http://www.wikidata.org/entity/Q39612212

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

2000年论文

@zh

2000年论文

@zh-cn

name

Sensitivity of human immunodef ...... efined by the V3 loop of gp120

@en

Sensitivity of human immunodef ...... fined by the V3 loop of gp120.

@nl

type

label

Sensitivity of human immunodef ...... efined by the V3 loop of gp120

@en

Sensitivity of human immunodef ...... fined by the V3 loop of gp120.

@nl

prefLabel

Sensitivity of human immunodef ...... efined by the V3 loop of gp120

@en

Sensitivity of human immunodef ...... fined by the V3 loop of gp120.

@nl

P1433

Q39612212-ADF99D5D-42C9-458B-A9C1-30566AA799AA

P1476

Q39612212-61C5CFE3-8AC1-43CD-BAD6-D107D8E4964D

P2093

Q39612212-269AAAC7-513E-4F68-9967-DFC13C4181CC

Q39612212-290E47D6-B07C-4BA7-BA09-617AB122D946

Q39612212-31DAB633-BAE1-443D-BC2B-BD0689079E20

Q39612212-3B2ABCCC-6D21-485C-87E7-DF4B7767E374

Q39612212-4FC7FD9F-1F23-45FE-BE8E-EE406CB9D496

Q39612212-85CB43A8-0966-45E3-9DF7-AB25B81C5B1C

Q39612212-A8E5F12E-41D3-4F0D-8CB7-063E82B740F1

Q39612212-BA7481EF-121F-4A70-8A7D-43D22963B004

Q39612212-CFAE290D-2088-490C-A968-724BE663CCB9

P2860

Q39612212-03247ACB-8075-4EF2-B8D4-D254DF7162A9

Q39612212-06254B46-B753-4043-A196-78763E1A5BD1

Q39612212-097140BD-2D86-4E98-9B80-6EEB40B0CD8B

Q39612212-0A066C9F-DD25-49FD-A39C-250F4979AC95

Q39612212-0E466CD9-C64F-45DA-9CAE-E5C55016BD0A

Q39612212-12D6A0C6-4C82-49EA-9146-EC7B47506C13

Q39612212-16568A12-4A50-48E3-A5A5-09C64F931319

Q39612212-1E4B4343-019F-4B93-913E-5C147111BC06

Q39612212-2078A49C-5EE5-4B2D-B143-4EB68A9FA7A1

Q39612212-298CC8A8-E84B-4697-A2D1-AC01CB82745D

P304

Q39612212-5BA945B0-659E-46EC-964B-B96EB9DDC3F0

P31

Q39612212-95B7D2BB-8BEC-4FE2-96C2-72C70FC06EA9

P356

Q39612212-42732F91-956D-415D-BE12-9407818C3266

P407

Q39612212-C8F1A764-FB14-48D0-9082-576D0F8DA0C3

P433

Q39612212-8AFF1DC3-81E7-4B10-94B2-6A7ED626296C

P478

Q39612212-E19D5B27-11B9-42DD-B979-46BEAE0DB1BD

P577

Q39612212-24968722-5BAE-42CB-8201-1E38F28A4687

P5875

Q39612212-FCE96ED8-52B2-4FDF-B308-1D8A680CF1D5

P698

Q39612212-CEBBCF23-046B-41EB-A1DB-378A515783DB

P921

Q39612212-A303C040-C7BB-4B47-8E46-AA154D899DD2

P932

Q39612212-F933E867-26FD-48E9-9884-95D71ED31158

P356

JVI.74.18.8358-8367.2000

P1433

Journal of Virology

P1476

Sensitivity of human immunodef ...... efined by the V3 loop of gp120

@en

P2093

C A Derdeyn

http://www.w3.org/2001/XMLSchema#string

E Hunter

http://www.w3.org/2001/XMLSchema#string

G M Shaw

http://www.w3.org/2001/XMLSchema#string

J C Kappes

http://www.w3.org/2001/XMLSchema#string

J M Decker

http://www.w3.org/2001/XMLSchema#string

J N Sfakianos

http://www.w3.org/2001/XMLSchema#string

L Ratner

http://www.w3.org/2001/XMLSchema#string

W A O'Brien

http://www.w3.org/2001/XMLSchema#string

X Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Expression cloning of new receptors used by simian and human immunodeficiency viruses

Structure of influenza haemagglutinin at the pH of membrane fusion

Core structure of gp41 from the HIV envelope glycoprotein

Atomic structure of the ectodomain from HIV-1 gp41

Atomic structure of a thermostable subdomain of HIV-1 gp41

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy

HIV entry and its inhibition

A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition

Sensitivity to a nonpeptidic compound (RPR103611) blocking human immunodeficiency virus type 1 Env-mediated fusion depends on sequence and accessibility of the gp41 loop region

P304

8358-8367

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.74.18.8358-8367.2000

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2000-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12365553

http://www.w3.org/2001/XMLSchema#string

P698

10954535

http://www.w3.org/2001/XMLSchema#string

P921

membrane fusion involved in viral entry into host cell

P932

116346

http://www.w3.org/2001/XMLSchema#string